Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

Value of SHOX2 and RASSF1A gene methylation in bronchoalveolar lavage fluid for diagnosis and prognostic assessment in lung cancer patients

Published on New Medicine 2026,36(6):624-630.
1435 times 675 times

HE Shaohua ZHANG Tianhui ZHOU Qin CHEN Cheng LIU Renshui YU Pengfei JIANG Li HE Zhihui XIE Wenxia TAN Liming

DNA methylation SHOX2 RASSF1A Lung cancer Prognostic biomarker
Details
Analysis of insulin resistance with bone mineral density and microstructure in adult males

Published on New Medicine 2026,36(6):617-623.
1288 times 633 times

QI Hanmei CHENG Peng CAI Jinmei LAI Bing ZHANG Aisen

Insulin resistance Bone mineral density Bone microstructure Trabecular bone score
Details
Application value of blood lithium monitoring in relapse prediction of maintenance treatment for bipolar disorder

Published on New Medicine 2026,36(6):611-616.
1577 times 672 times

JIANG Wei WANG Weige FENG Nan LIU Jinsong

Bipolar disorder Mean serum lithium level Thyroid-stimulating hormone Relapse prediction Logistic regression
Details
Research on living clinical practice guidelines in diabetes mellitus Ⅲ: methodological characteristics analysis of recommendations classification and evidence grading in the Chinese clinical practice guidelines for type 2 diabetes mellitus

Published on New Medicine 2026,36(6):605-610.
1917 times 732 times

WU Ajiao CAI Fengyi XIE Chi WANG Shichun WANG Yongbo YAN Siyu HUANG Qiao REN Xiangying JIN Yinghui TANG Jun

Type 2 diabetes mellitus Clinical practice guidelines Evidence grading Grade of recommendation
Details
A case report of severe thrombocytopenia caused by piperacillin-tazobactam in combination with voriconazole

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):710-715.
1735 times 437 times

WANG Jinming LI Xueyan

Piperacillin-tazobactam Voriconazole Thrombocytopenia Adverse reactions
Details
Cross-reaction between ceftizoxime and ceftriaxone inducing autoimmune hemolytic anemia in children: a case report

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):705-709.
1627 times 445 times

LI Wen LI Gen JIANG Yongxian HU Siqi ZHANG Bo

Ceftizoxime Ceftriaxone Autoimmune hemolytic anemia Cross-reaction Adverse reactions
Details
Rosuvastatin-induced ocular myasthenia gravis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):700-704.
1760 times 414 times

WEN Chao WANG Min LI Yali WU Panting TAO Xuxia TANG Xiaoxia

Rosuvastatin Statins Ocular myasthenia gravis Adverse drug reaction
Details
Research progress on the treatment of sarcopenia by traditional Chinese medicine regulating the PI3K/Akt/mTOR signaling pathway

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):689-699.
2272 times 446 times

ZHAO Rongcan ZHAO Liang

Sarcopenia PI3K/Akt/mTOR signaling pathway Traditional Chinese medicine monomer Traditional Chinese medicine compound Mechanism of action
Details
Bibliometric analysis of medication safety studies in pediatric atopic dermatitis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):679-688.
1462 times 439 times

WEI Fenfang HUANG Leyi LI Limin WU Jianru LIU Xiaoyu

Children Eczema Atopic dermatitis Safe medication Bibliometrics
Details
Efficacy and safety of galcanezumab in the treatment of migraine in adults: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):669-678.
1581 times 378 times

HE Xiaodong LI Qin KE Changhu LI Chunlei LIU Huimin

Galcanezumab Migraine Randomized controlled trial Systematic review Meta-analysis
Details
Real-world study of generic versus branded meropenem in the treatment of hospital-acquired pneumonia patients with traumatic brain injury

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):660-668.
1863 times 515 times

SHEN Jie TANG Lian CHEN Xianglong YANG Lijuan LI Tongtong MA Mian DENG Peng XU Jinhui

Meropenem Generic drug Branded drug Hospital-acquired pneumonia Traumatic brain injury Efficacy Safety Economy
Details
Post-marketing safety evaluation of nirsevimab based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):653-659.
1695 times 421 times

NIU Rui LIU Wei ZHAO Kai ZHANG Wenqian ZHAO Fang

Nirsevimab Respiratory syncytial virus Pharmacovigilance Adverse drug reactions
Details
Analysis of the association between analgesic drug use and asthma in different body fat levels: a cross-sectional study based on NHANES

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):645-652.
1363 times 393 times

ZHANG Sisi WANG Wutao HAN Bin ZHAO Ling LI Zhengwei QIAO Yan ZHANG Lei

Opioid analgesics Non-opioid analgesics Asthma Percent fat Associavtion NHANES
Details
Survey on knowledge, attitudes, and practices among residents in the Ningxia and analysis of influencing factors

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):635-644.
1436 times 393 times

SUN Lixia ZHANG Xiaoli JI Hongyan

Knowledge-attitude-practice Medication risks Medication safety Influencing factors
Details
Development of a predictive model for the risk of antimicrobial drug-induced thrombocytopenia using 5 machine learning algorithms

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):625-634.
1577 times 401 times

WANG Min SHEN Xiaoyan

Machine learning Antimicrobial drugs Thrombocytopenia Prediction model Risk factors Extreme gradient boosting SHapley Additive exPlanation
Details
Interpretation of the Transparent Reporting of Observational Studies Emulating a Target Trial (TARGET) statement

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):613-624.
1916 times 483 times

LIN Tengfei WU Xiaoyu HE Na LONG Yujun YANG Nan QIU Yijin ZHANG Tiantian XU Yang YANG Zhirong

Observational study Target trial emulation Reporting guideline TARGET statement Causal inference
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (18): analysis strategies and clinical applications of heterogeneity of treatment effect

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):601-612.
1696 times 444 times

HUANG Tao SHEN Zhuoheng XU Yang

Heterogeneity of treatment effect Pharmacoepidemiology Real-world data Subgroup analysis Risk modelling Effect modelling Causal machine learning Precision medicine
Details
Analysis of one case of almolertinib-induced interstitial lung disease in a lung cancer patient

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):895-900.
2031 times 416 times

FAN Xinxing LI Ling ZHENG Menying BAI Juan

Almonertinib Interstitial lung disease Lung cancer Adverse drug reaction
Details
Interpretation of the Guiding Principles of Good AI Practice in Drug Development jointly released by FDA and EMA

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):885-894.
2942 times 904 times

ZHANG Hua LI Pengfei FU Hongjun

U.S. Food and Drug Administration European Medicines Agency Ar-tificial intelligence Drug development Guide principles Regulatory science
Details
Research progress on optimized technical paths of meloxicam dosage forms

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):876-884.
1632 times 374 times

YANG Jie YUAN Jing XU Shaohua LIAO Zongquan XIAO Gaofeng QU Longmei

Meloxicam Dosage form Drug delivery system Targeted preparations Sustained-release preparations Cyclooxygenase-2
Details